INTERACTION OF IODINATED QUINUCLIDINYL BENZILATE ENANTIOMERS WITH M(3) MUSCARINIC RECEPTORS

被引:3
|
作者
HIRAMATSU, Y
ECKELMAN, WC
BAUM, BJ
机构
[1] NIDR,CIPCB,BETHESDA,MD 20892
[2] NIH,CTR CLIN,DEPT POSITRON EMISS TOMOG,BETHESDA,MD 20892
关键词
MUSCARINIC RECEPTORS; QUINUCLIDINYL IODOBENZILATE ENANTIOMERS; M(3)-MACHRS;
D O I
10.1016/0024-3205(94)90116-3
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We examined the interaction of 3-quinuclidinyl-4-iodobenzilate enantiomers, (RR)- and (SS)-IQNB, relatively receptor-active and -inactive, respectively, with M(3)-muscarinic receptors (mAChRs) in rat parotid acinar cells in vitro. This stereospecific antagonist pair has often been used for in vivo studies of mAChRs. There was a 16-fold difference in the ability of(RR)- and (SS)-IQNB to bind in vitro to mAChRs; K-i values estimated by competition with N-methylscopolamine were 5.3 and 84.2nM, respectively. However, the ability of these antagonists to inhibit carbachol-stimulated inositol trisphosphate formation (K-i values determined by Schild analyses) was more similar, 16.3 and 47.7nM, respectively for (RR)- and (SS)-IQNB. These data suggest that while it may be useful to employ this antagonist pair to evaluate some mAChR subtypes in vivo, it is difficult to use them in studies of M(3)-mAChRs.
引用
收藏
页码:1777 / 1783
页数:7
相关论文
共 50 条
  • [41] CHARACTERIZATION OF HIGH-AFFINITY [H-3] PIRENZEPINE AND (-)-[H-3] QUINUCLIDINYL BENZILATE BINDING TO MUSCARINIC CHOLINERGIC RECEPTORS IN RABBIT PERIPHERAL LUNG
    BLOOM, JW
    HALONEN, M
    LAWRENCE, LJ
    ROULD, E
    SEAVER, NA
    YAMAMURA, HI
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1987, 240 (01): : 51 - 58
  • [42] A convenient synthesis of the muscarinic cholinergic antagonist (R)-[N-methyl-3H]quinuclidinyl benzilate methiodide
    Filer, Crist N.
    Seguin, Richard J.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 (09): : 604 - 607
  • [43] THE BINDING OF H-3 QUINUCLIDINYL BENZILATE TO CHOLINERGIC MUSCARINIC RECEPTORS IN RAT-BRAIN REGION FOLLOWING CHRONIC TREATMENT WITH MORPHINE AND DURING ABSTINENCE
    DAS, S
    MATWYSHYN, GA
    BHARGAVA, HN
    NEUROPEPTIDES, 1984, 5 (1-3) : 45 - 48
  • [44] INFLUENCE OF FREE FATTY-ACIDS ON THE SPECIFIC BINDING-PROPERTIES OF THE ANTAGONIST 3H-QUINUCLIDINYL BENZILATE AT MUSCARINIC RECEPTORS IN THE VENTRICULAR MYOCARDIUM
    RAUCH, B
    MESSINEO, FC
    COLVIN, RA
    KATZ, AM
    ZEITSCHRIFT FUR KARDIOLOGIE, 1987, 76 : 60 - 60
  • [45] INVIVO DISSOCIATION KINETICS OF [H-3] QUINUCLIDINYL BENZILATE - RELATIONSHIP TO MUSCARINIC RECEPTOR CONCENTRATION AND INVITRO KINETICS
    GIBSON, RE
    ZEEBERG, BR
    MELOGRANA, JM
    WANG, TF
    RUCH, J
    BRAUN, A
    REBA, RC
    BRAIN RESEARCH, 1991, 553 (01) : 110 - 116
  • [46] TOXINS FROM THE VENOM OF THE GREEN MAMBA DENDROASPIS-ANGUSTICEPS THAT INHIBIT THE BINDING OF QUINUCLIDINYL BENZILATE TO MUSCARINIC ACETYLCHOLINE-RECEPTORS
    ADEM, A
    ASBLOM, A
    JOHANSSON, G
    MBUGUA, PM
    KARLSSON, E
    BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 968 (03) : 340 - 345
  • [47] [QUINUCLIDINYL-H-3 BENZILATE BINDING TO MUSCARINIC RECEPTORS IN RAT-BRAIN - COMPARISON OF RESULTS FROM INTACT BRAIN-SLICES AND HOMOGENATES
    GILBERT, RFT
    HANLEY, MR
    IVERSEN, LL
    BRITISH JOURNAL OF PHARMACOLOGY, 1979, 65 (03) : 451 - 456
  • [48] 3-Quinuclidinyl benzilate (agent BZ) toxicokinetics in rats
    Dlabkova, Alzbeta
    Herman, David
    Cechova, Lenka
    Hroch, Milos
    Vanova, Nela
    Karasova, Jana Zdarova
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2021, 129 (03) : 246 - 255
  • [49] MUSCARINIC CHOLINERGIC RECEPTORS IN HUMAN-FETAL BRAIN - CHARACTERIZATION AND ONTOGENY OF [H-3] QUINUCLIDINYL BENZILATE BINDING-SITES IN FRONTAL-CORTEX
    RAVIKUMAR, BV
    SASTRY, PS
    JOURNAL OF NEUROCHEMISTRY, 1985, 44 (01) : 240 - 246
  • [50] COMPARISON OF 2 RADIOLABELED QUINUCLIDINYL BENZILATE LIGANDS FOR THE CHARACTERIZATION OF THE HUMAN PERIPHERAL LUNG MUSCARINIC RECEPTOR
    JOAD, JP
    CASALE, TB
    LIFE SCIENCES, 1987, 41 (13) : 1577 - 1584